JAIME SCHOFIELD: Open Payments
NPI 1124204987 · SELLERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,680 in 69 payments from 31 companies in 2025. Trend: 2023 $1,483 · 2024 $1,638 · 2025 $1,680
Food & beverage: $1,657Education: $23
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $166 |
| AstraZeneca Pharmaceuticals LP | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Incyte Corporation | 4 | $100 |
| Celgene Corporation | 3 | $90 |
| BeOne Medicines USA, Inc. | 3 | $88 |
| Janssen Biotech, Inc. | 4 | $86 |
| ABBVIE INC. | 3 | $79 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $75 |
Products named: Enhertu, REBLOZYL, BRUKINSA, Nubeqa, Lenvima, Xtandi, OJJAARA, ELAHERE.
Industry payments across PA — which companies pay providers there.
